History

2019
09
  • Acquired GMP for health functional foods
07
  • Received Nano Korea 2019 Award from the Minister of Ministry of Trade, Industry and Energy
02
  • Licensing agreement with Pharmbio Korea Inc.
2018
10
  • Initiation of dose-fining clinical trial of BS-104
08
  • BS-102 selected as a promising cancer nanomedicine candidate by NCL (National Cancer Institute’s Nanotechnology Characterization Laboratory) for its Assay Cascade characterization and testing program
08
  • Establishment of GMP NUFS facility for supplying clinical trial medicines
2017
12
  • Listed on the KONEX stock market
12
  • R&D collaboration agreement (RDCA) and licensing agreement with Samyang BioPharm.
11
  • Investment from Premier Partners, LLC.
2016
09
  • Participation in a Korean government funded anti-cancer drug development project (KRW 4 billion / 4 years)
2015
12
  • Investment from Korea Investment Partners Co., Ltd.
2014
09
  • SENS™ patent registered in the U.S. and China
03
  • NUFS™ patent registered in major EU countries
2013
11
  • RDCA and licensing agreement with Daewoong Pharm.
2012
07
  • NUFS™ patent registered in the U.S.
07
  • R&D agreement with Amway (Improved Bioavailability Material Development)
02
  • Presentation for Nanoparticluation Technology in Biopartnering North America
2011
12
  • Government funded project for innovative cancer research with Asan Medical Center
11
  • Research & manufacturing agreement with Doosan (Ceramide)
08
  • NUFS™ patent registered in Japan
2010
01
  • Presentation for NUFS™ Technology Application (BS-102) in IGCS (International Gynecological Cancer Society) 2010
2009
09
  • NUFS™ patent registered in China and Australia
08
  • R&D agreement with PharmaKing
2008
10
  • Participation in Korea BizBiz Day (Frankfurt / New Jersey / Osaka) Technology Presentation and Partnering
2007
04
  • R&D collaboration agreement with JW Pharma.
2006
07
  • NUFS™ patent registered in Korea
2005
05
  • Certified as a “Venture company with new technology”
2004
01
  • Establishment of Bio-Synectics, Inc.